LCLAT1-EPHA3 Fusion FISH Probe
The LCLAT1-EPHA3 Fusion FISH Probe is used to confirm a fusion of the LCLAT1 and EPHA3 genes. The fusion of the LCLAT1 and EPHA3 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| LCLAT1-EPHA3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| LCLAT1-EPHA3-20-AQAQ | 20 (40 μL) | 200 μL |
|
EPHA3 Gene Summary
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]
Gene Name: EPH Receptor A3
Chromosome: CHR3: 89156673 -89531284
Locus: 3p11.1
LCLAT1 Gene Summary
The Lysocardiolipin Acyltransferase 1 (LCLAT1) gene is located on chr2 :30670122-30867091 at 2p23.1.
Gene Name: Lysocardiolipin Acyltransferase 1
Chromosome: CHR2: 30670122 -30867091
Locus: 2p23.1
Gene Diseases
The LCLAT1 EPHA3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|